EASL Studio S9 E12: Collaborating across disciplines to find the best solution for people living with PBC

EASL Studio S9 E11: What Can Be Done to Safeguard Young Adults from SLD?

EASL Studio S9 E10: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

EASL Studio S9 E09: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance

EASL Studio S9 E08: MASLD in Practice: Who to Treat, With What, and for How Long?

EASL Studio S9 E07: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports?

EASL Studio S9 E06: Are we finally entering an era of effective treatment for PSC?

EASL Studio S9 E05: Does it really matter whether we call it ACLF or acute decompensation?

EASL Studio S9 E04: The Clinical Blind Spot: Are We Neglecting Alcohol?

EASL Studio S9 E03: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?

EASL Studio S9 E02: What Matters Most? The questions every hepatologist should ask their patients

EASL Studio S9 E1: Treating PBC: Alkaline Phosphatase response or improvement in liver stiffness?